Last €12.95 EUR
Change Today -0.138 / -1.05%
Volume 0.0
APS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:44 AM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Edward M. Fitzgerald

Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Treasurer, Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

57$1,946,619
As of Fiscal Year 2012

Background*

Mr. Edward M. Fitzgerald has been the Chief Financial Officer and Treasurer of ARIAD Pharmaceuticals, Inc. since May 2002 and has been its Executive Vice President since June 2010 and serves as Principal Accounting Officer. Mr. Fitzgerald served as Senior Vice President of Finance & Corporate Operations at Ariad Pharmaceuticals Inc. From 1998 to April 2002, Mr. Fitzgerald served as Senior Vice President, Chief Financial Officer and Secretary of Twin Butte Energy Ltd. ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139-4234

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Babson College
MBA
Babson College

Other Affiliations*

Annual Compensation*

Salary$436,461
Bonus$329,000
Total Annual Compensation$765,461

Stock Options*

Restricted Stock Awards$376,250
All Other Compensation$29,636
Exercised Options100,000
Exercised Options Value$1,114,400
Exercisable Options305,667
Exercisable Options Value$4,037,637
Unexercisable Options116,333
Unexercisable Options Value$1,044,213
Total Value of Options$6,196,250
Total Number of Options522,000

Total Compensation*

Total Annual Cash Compensation$795,097
Total Short Term Compensation$765,461
Other Long Term Compensation$405,886
Total Calculated Compensation$1,946,619
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APS:GR €12.95 EUR -0.138

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$193.6K
Daniel R. Passeri MSc., J.D.Chief Executive Officer and Director
Curis, Inc.
$601.9K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Paul A. Friedman M.D.Chief Executive Officer, President, Director, Member of Non-Management Stock Option Committee and Member of Finance Committee
Incyte Corporation
$666.5K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$536.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.